Literature DB >> 17302906

Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice.

J C Flynn1, C Meroueh, D P Snower, C S David, Y M Kong.   

Abstract

Both genetic and environmental factors contribute to autoimmune disease development. Previously, we evaluated genetic factors in a humanized mouse model of Hashimoto's thyroiditis (HT) by immunizing human leucocyte antigen DR3 (HLA-DR3) and HLA-DQ8 transgenic class II-knock-out non-obese diabetic (NOD) mice. DR3+ mice were susceptible to experimental autoimmune thyroiditis (EAT) induction by both mouse thyroglobulin (mTg) and human (h) Tg, while DQ8+ mice were weakly susceptible only to hTg. As one environmental factor associated with HT and tested in non-transgenic models is increased sodium iodide (NaI) intake, we examined the susceptibility of DR3+ and/or DQ8+ mice to NaI-induced disease. Mice were treated for 8 weeks with NaI in the drinking water. At 0 x 05% NaI, 23% of DR3+, 0% of DQ8+ and 20% of DR3+DQ8+ mice had thyroid destruction. No spleen cell proliferation to mTg was observed. Most mice had undetectable anti-mTg antibodies, but those with low antibody levels usually had thyroiditis. At 0.3% NaI, a higher percentage of DR3+ and DR3+DQ8+ mice developed destructive thyroiditis, but it was not statistically significant. However, when DR3+ mice had been depleted of CD4+CD25+ regulatory T cells prior to NaI treatment, destructive thyroiditis (68%) and serum anti-mTg antibodies were exacerbated further. The presence of DQ8 molecules does not alter the susceptibility of DR3+DQ8+ mice to NaI-induced thyroiditis, similar to earlier findings with mTg-induced EAT. Susceptibility of DR3+ mice to NaI-induced EAT, in both the presence and absence of regulatory T cells, demonstrates the usefulness of HLA class II transgenic mice in evaluating the roles of environmental factors and immune dysregulation in autoimmune thyroid disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302906      PMCID: PMC1810500          DOI: 10.1111/j.1365-2249.2006.03303.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

1.  Is focal chronic autoimmune thyroiditis an age-related disease? Differences in incidence and severity between Japanese and British.

Authors:  I Okayasu; S Hatakeyama; Y Tanaka; T Sakurai; K Hoshi; P D Lewis
Journal:  J Pathol       Date:  1991-03       Impact factor: 7.996

2.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

3.  Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis.

Authors:  I Okayasu; Y Hara; K Nakamura; N R Rose
Journal:  Am J Clin Pathol       Date:  1994-06       Impact factor: 2.493

4.  Tolerance to thyroglobulin by activating suppressor mechanisms.

Authors:  Y M Kong; I Okayasu; A A Giraldo; K W Beisel; R S Sundick; N R Rose; C S David; F Audibert; L Chedid
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  In vitro T-lymphocyte proliferative response to mouse thyroglobulin in experimental autoimmune thyroiditis.

Authors:  I Okayasu; Y M Kong; C S David; N R Rose
Journal:  Cell Immunol       Date:  1981-06       Impact factor: 4.868

6.  Resistance to experimental autoimmune thyroiditis induced by physiologic manipulation of thyroglobulin level.

Authors:  M Lewis; A A Giraldo; Y C Kong
Journal:  Clin Immunol Immunopathol       Date:  1987-10

7.  Mice lacking MHC class II molecules.

Authors:  D Cosgrove; D Gray; A Dierich; J Kaufman; M Lemeur; C Benoist; D Mathis
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

8.  Thyroid cell injury is an initial event in the induction of autoimmune thyroiditis by iodine in obese strain chickens.

Authors:  N Bagchi; T R Brown; R S Sundick
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

9.  Depletion of CD4+ and CD8+ cells eliminates immunologic memory of thyroiditogenicity in murine experimental autoimmune thyroiditis.

Authors:  B E Fuller; A A Giraldo; H Waldmann; S P Cobbold; Y C Kong
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815

10.  Primary hormonogenic sites as conserved autoepitopes on thyroglobulin in murine autoimmune thyroiditis. Secondary role of iodination.

Authors:  Y C Kong; D J McCormick; Q Wan; R W Motte; B E Fuller; A A Giraldo; C S David
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

View more
  6 in total

Review 1.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 2.  Establishing humanized mice using stem cells: maximizing the potential.

Authors:  D Bernard; M Peakman; A C Hayday
Journal:  Clin Exp Immunol       Date:  2008-04-24       Impact factor: 4.330

3.  Circulating lymphocyte subsets and regulatory T cells in patients with postpartum thyroiditis during the first postpartum year.

Authors:  Xiaoguang Shi; Chenyang Li; Yushu Li; Haixia Guan; Chenling Fan; Ying Teng; Yuhong Ouyang; Zhongyan Shan; Weiping Teng
Journal:  Clin Exp Med       Date:  2009-05-06       Impact factor: 3.984

Review 4.  Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.

Authors:  Yi-chi M Kong; Jennifer B Jacob; Jeffrey C Flynn; Bruce E Elliott; Wei-Zen Wei
Journal:  Autoimmun Rev       Date:  2009-02-28       Impact factor: 9.754

5.  Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells.

Authors:  Su He Wang; Gwo-Hsiao Chen; Yongyi Fan; Mary Van Antwerp; James R Baker
Journal:  Endocrinology       Date:  2008-11-13       Impact factor: 4.736

6.  CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients.

Authors:  Oğuz Biylgi; Bülent Karagöz; Orhan Türken; Mustafa Gültepe; Alpaslan Özgün; Tolga Tunçel; Levent Emirzeoğlu; Serkan Çelik; Tuba Müftüoğlu; Emin Gökhan Kandemir
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.